Ongoing advancement in technology, leads to increased development of parenteral drugs—one of the fastest growing choice for drug delivery in patients. Typically, manufacturing companies fill vials of products and ship them to physicians, pharmacies, etc. with an unfilled syringe; therefore, creating more work for all parties involved. Introducing prefilled syringes could cut manufacturing costs and…
Read more
Starting your Sterile Injectables Program off on the Right Foot
Injectable drug products need to have an extreme and successful sterile fill to finish. How do you ensure your manufacturers obtain the highest level of operational and quality excellence? Manufacturing environments must be tightly controlled—especially due to the increase in demand of sterile injectables. Qualifying every part of the product leading up to the final…
Read more
Mylan Pharmaceuticals Inc. Conducting Voluntary Nationwide Recall of Insulin Injection
On April 12, 2022, Mylan Pharmaceuticals Inc. recalled one batch of insulin. Labels were missing on one batch of Insulin Glargine Injection. This package is an unbranded Insulin Glargine- yfgn vial and product information, batch number and expiry date information are present on the carton. Insulin Glargine was distributed in the United States between December…
Read more
SYMJEPI Defect Recall
Imagine having an allergic reaction and the medication to save your life cannot be dispensed. SYMJEPI is an emergency treatment for patients who have an allergic reaction to something or anaphylaxis to stinging insects, allergen immunotherapy, foods, drugs, diagnostic testing substances and more. This injection is an emergency Epinephrine medication that is injected into patient…
Read more